Melanocortin receptor agonists

Details for Australian Patent Application No. 2004275928 (hide)

Owner Novo Nordisk A/S

Inventors Johansen, Nils Langeland; CondeFrieboes, Kilian Waldemar; Hansen, Thomas Kruse; Wulff, Birgitte Schjellerup; Madsen, Kjeld; Sensfuss, Ulrich; Christensen, Leif

Agent Shelston IP

Pub. Number AU-B-2004275928

PCT Pub. Number WO2005/030797

Priority PA 2003 01417 30.09.03 DK

Filing date 29 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 11 March 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/68 (2006.01) Peptides having more than 20 amino acids

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030797 Priority application(s): WO2005/030797

11 March 2010 Application Accepted

  Published as AU-B-2004275928

8 July 2010 Standard Patent Sealed

21 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275929-A method of modulating cell survival, differentiation and/or synaptic plasticity

2004275903-Oligonucleotide compositions and methods for treating disease including inflammatory conditions